Health and Childcare Minister Douglas Mombeshora says the new long-acting HIV prevention jab, Lenacapavir, will be given free of charge to everyone who qualifies — in line with the country’s policy of providing all HIV medicines at no cost.
The breakthrough drug, which only needs two injections a year, is expected to arrive in Zimbabwe in January 2026.
Speaking to journalists in Harare on Thursday, 27 November, Mombeshora said staff training has already begun, and rollout sites have been identified. He said:
“This drug was very expensive, but because discussions have taken place, the company which is producing the drug has agreed to lower the cost to a level where it will cost US$40 per year, which becomes very affordable. Remember, it’s only two doses per year.
“Our rollout plan is now completely in order. Some training has been done for the medical staff, and sites for the rollout have been identified. Hopefully, in January, we will receive those doses and start the program.
“All our HIV programs are free, so this preventive drug will also be administered for free for those who will be enrolled in the rollout program.”
The drug, approved by the Medicines Control Authority of Zimbabwe (MCAZ) on 22 November 2025 after a swift 23-day expedited review due to its public health importance, will be prioritised for vulnerable populations. Added Mombeshora:
“This medicine is intended for people at substantial risk of acquiring HIV, including adolescent girls and young women, pregnant and breastfeeding women, key populations, and mobile workers.”
The new twice-yearly injectable is expected to play a key role in closing HIV prevention gaps and speeding up progress towards the UNAIDS 95-95-95 targets.
Pindula WhatsApp Channel
Facebook Page
Leave a Reply